Latest Breaking News On - பார்மா உலகளாவிய - Page 1 : comparemela.com

Strides gets USFDA nod for Potassium Chloride for Oral Solution March 15, 2021 Used for prevention, treatment of low blood levels of potassium Strides Pharma Science Limited (Strides) has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for Potassium Chloride for Oral Solution USP, 20 mEq from the United States Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Potassium Chloride for Oral Solution USP, 20 mEq, of Pharma Research Software Solution, LLC. Potassium Chloride Oral Solution is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient.

United statesPharma research software solutionDrug administrationStrides pharma global pte ltdStrides pharma sciencePotassium chlorideOral solutionPharma globalUnited states foodStrides pharmaChloride oral solutionLow blood levelsஒன்றுபட்டது மாநிலங்களில்பார்மா ஆராய்ச்சி மென்பொருள் தீர்வுமுன்னேற்றங்கள் பார்மா உலகளாவிய ட் லிமிடெட்முன்னேற்றங்கள் பார்மா அறிவியல்